Literature DB >> 22143278

Myotonic dystrophies and the heart.

Sunit-Preet Chaudhry1, William H Frishman.   

Abstract

Myotonic dystrophy (MD) is a neuromuscular disorder of autosomal dominant inheritance, which is categorized by 2 main sub-types: type 1 (MD1) and type 2 (MD2). This disease is characterized by myotonia and various multisytemic complications, most commonly of the cardiac, endocrine, and central nervous systems. In addition, cardiac abnormalities contribute to a significant morbidity and mortality in these patients. The cardiac abnormalities common to MD1 are conduction defects, such as first-degree atrioventricular block, arrhythmias, and other less common manifestations such as heart failure, ischemic heart disease, and mitral valve prolapse. Although these cardiac manifestations are also common in MD2, another complication that has been linked to MD2 is cardiomyopathy. Further study needs to be performed to better understand the pathology and management of these cardiac disorders associated with MD.

Entities:  

Mesh:

Year:  2012        PMID: 22143278     DOI: 10.1097/CRD.0b013e31821950f9

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  8 in total

Review 1.  Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging.

Authors:  Georgios M Alexandridis; Efstathios D Pagourelias; Nikolaos Fragakis; Maria Kyriazi; Efthymia Vargiami; Dimitrios Zafeiriou; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2022-07-20       Impact factor: 4.654

2.  Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophy.

Authors:  Yongping Yue; Ibrahim M Binalsheikh; Stacey B Leach; Timothy L Domeier; Dongsheng Duan
Journal:  Expert Opin Orphan Drugs       Date:  2015-12-17       Impact factor: 0.694

3.  Myotonic dystrophy type 1 presenting with stroke-like episodes: a case report.

Authors:  Jens D Rollnik; Ute Heinz; Olaf Lenz
Journal:  BMC Res Notes       Date:  2013-06-26

4.  Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction.

Authors:  Mouli Chakraborty; Estela Selma-Soriano; Emile Magny; Juan Pablo Couso; Manuel Pérez-Alonso; Nicolas Charlet-Berguerand; Ruben Artero; Beatriz Llamusi
Journal:  Dis Model Mech       Date:  2015-10-29       Impact factor: 5.758

5.  Muscleblind-like 1 is required for normal heart valve development in vivo.

Authors:  Ryan J Coram; Samantha J Stillwagon; Anuradha Guggilam; Michael W Jenkins; Maurice S Swanson; Andrea N Ladd
Journal:  BMC Dev Biol       Date:  2015-10-15       Impact factor: 1.978

Review 6.  The heart and cardiac pacing in Steinert disease.

Authors:  Gerardo Nigro; Andrea Antonio Papa; Luisa Politano
Journal:  Acta Myol       Date:  2012-10

7.  Identification and characterization of DM1 patients by a new diagnostic certified assay: neuromuscular and cardiac assessments.

Authors:  Rea Valaperta; Valeria Sansone; Fortunata Lombardi; Chiara Verdelli; Alessio Colombo; Massimiliano Valisi; Elisa Brigonzi; Elena Costa; Giovanni Meola
Journal:  Biomed Res Int       Date:  2013-05-09       Impact factor: 3.411

Review 8.  Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy.

Authors:  Elizabeth M McNally; Douglas L Mann; Yigal Pinto; Deepak Bhakta; Gordon Tomaselli; Saman Nazarian; William J Groh; Takuhisa Tamura; Denis Duboc; Hideki Itoh; Leah Hellerstein; Pradeep P A Mammen
Journal:  J Am Heart Assoc       Date:  2020-02-06       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.